demonstrated that oridonin exerted a therapeutic effect towards atherosclerosis through NACHT, LRR and PYD domain containing protein 3 (NLRP3) and nuclear factor E2‐related factor 2 (Nrf2). Here, NLRP3 is linked to atherosclerosis.